טוען...
Preclinical pharmacological profile of nomegestrol acetate, a synthetic 19-nor-progesterone derivative
BACKGROUND: Nomegestrol acetate (NOMAC), a synthetic progestogen derived from 19-nor-progesterone, recently completed clinical trials for use with 17beta-estradiol in a new monophasic combined oral contraceptive. In this review, published as well as previously unpublished preclinical studies that de...
שמור ב:
| מחבר ראשי: | |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3571880/ https://ncbi.nlm.nih.gov/pubmed/23043680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7827-10-85 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|